Literature DB >> 16696054

Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?

M K Fagerhol1.   

Abstract

Year:  1996        PMID： 16696054      PMCID： PMC408025          DOI： 10.1136/mp.49.2.m74

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN： 1355-2910


× No keyword cloud information.
  30 in total

1.  Epidermal expression of the calcium binding surface antigen 27E10 in inflammatory skin diseases.

Authors:  M Kunz; J Roth; C Sorg; G Kolde
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  The distribution of the antimicrobial protein, calprotectin, in normal oral keratinocytes.

Authors:  L R Eversole; K T Miyasaki; R E Christensen
Journal:  Arch Oral Biol       Date:  1992-11       Impact factor: 2.633

3.  Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells.

Authors:  J Edgeworth; M Gorman; R Bennett; P Freemont; N Hogg
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

4.  L1, a major granulocyte protein; isolation of high quantities of its subunits.

Authors:  H B Berntzen; M K Fagerhol
Journal:  Scand J Clin Lab Invest       Date:  1990-11       Impact factor: 1.713

5.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

6.  Identification of 'cystic fibrosis protein' as a complex of two calcium-binding proteins present in human cells of myeloid origin.

Authors:  C Barthe; C Figarella; J Carrère; O Guy-Crotte
Journal:  Biochim Biophys Acta       Date:  1991-02-22

7.  The L1 antigen and squamous metaplasia in the bladder.

Authors:  M F Tungekar; A Heryet; K C Gatter
Journal:  Histopathology       Date:  1991-09       Impact factor: 5.087

8.  Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein).

Authors:  C F Naess-Andresen; B Egelandsdal; M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1995-10

9.  Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils.

Authors:  P G Sohnle; C Collins-Lech; J H Wiessner
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

10.  Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis.

Authors:  H Berner Berntzen; G K Endresen; M K Fagerhol; J Spiechowicz; P Mowinckel
Journal:  Scand J Clin Lab Invest       Date:  1991-11       Impact factor: 1.713
View more
  6 in total

1.  Plasma calprotectin levels in patients suffering from acute pancreatitis.

Authors:  Antonio Carroccio; Pasquale Rocco; Pier Giorgio Rabitti; Lidia Di Prima; Giovanni Battista Forte; Angelo B Cefalù; Franco Pisello; Girolamo Geraci; Generoso Uomo
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 2.  Calprotectin: Clinical Applications in Pediatrics.

Authors:  Oscar R Herrera; Michael L Christensen; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jul-Aug

3.  Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.

Authors:  Britta Noebauer; Lejla Ramic; Andrea Konstantin; Christina Zachbauer; Elisa Einwallner
Journal:  Biochem Med (Zagreb)       Date:  2017-10-15       Impact factor: 2.313

4.  Fecal calprotectin in healthy children aged 4-16 years.

Authors:  María Roca; Ana Rodriguez Varela; Eva Carvajal; Ester Donat; Francisco Cano; Ana Armisen; Maria Jose Vaya; Helena Ekoff; David Hervas; Niclas Rydell; Carmen Ribes-Koninckx
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

5.  Fecal Calprotectin in Healthy Children Aged 1-4 Years.

Authors:  Qingling Zhu; Feng Li; Junli Wang; Lixiao Shen; Xiaoyang Sheng
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

6.  Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs).

Authors:  Elcha Charles; Benjamin L Dumont; Steven Bonneau; Paul-Eduard Neagoe; Louis Villeneuve; Agnès Räkel; Michel White; Martin G Sirois
Journal:  BMC Immunol       Date:  2021-08-03       Impact factor: 3.615
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.